Answers are grounded in this paper and cite their sources.
A fragment-based development of 3C-triazol-1-yl-O-galactopyranosyl aldoximes led to the discovery of highly selective and high affinity (K(d) down to 11 microm) small monosaccharide based inhibitors of galectin-3. Galectin-7, 8 N-terminal CRD, and 9 N-terminal CRD bound the inhibitors only weakly. The galectin-3 selectivity was hypothesized to stem from interaction of the aldoxime moiety with a site not present in the other galectins.
No takes yet. Share an insight, caveat, or question.
Tejler et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: